Atlas Trials

Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study

Clinical trial NCT07004868 · RECRUITING

Trial details

NCT number
NCT07004868
Sponsor
University Hospital, Tours
Status
RECRUITING
Study type
OBSERVATIONAL
Lung Cancer (NSCLC)
Start date
2025-06-03
Primary completion
2030-06-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.